SEC Filing Summary: Renovaro Inc. (RENB)
Business Context and Reporting Period
This Form 8-K was filed by Renovaro Inc. (not Lunai Bioworks Inc.) on April 18, 2025, reporting an event that occurred on April 14, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "RENB".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
On April 14, 2025, Renovaro Inc. received a deficiency notice from Nasdaq stating that its common stock failed to comply with the $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)). This failure was based on the closing bid price for the 30 consecutive business days prior to the notice. There is no immediate effect on the listing, and the stock continues to trade.
Guidance, Outlook, and Risks
- Compliance Period: The company has an initial 180-day compliance period ending on October 13, 2025.
- Requirement to Cure: To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the deadline.
- Secondary Compliance: If the company fails to comply by October 13, 2025, it may be eligible for an additional 180-day period, provided it meets other listing standards (e.g., market value of publicly held shares) and notifies Nasdaq of its intent to cure.
- Delisting Risk: Failure to qualify for or succeed in the second compliance period will result in a determination to delist the common stock, subject to an appeal process.
- Management Action: The company intends to monitor the stock price and is considering options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of RENB to assess the gap from the $1.00 threshold.
- Monitor the company's announcements regarding potential reverse stock splits or other capital structure changes intended to raise the share price.
- Check the company's market value of publicly held shares to determine eligibility for a second compliance period if the first is missed.
- Review subsequent filings for updates on the compliance status before the October 13, 2025 deadline.